Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allelotype analysis of hepatocellular carcinoma

Z Piao1, C Park, J H Park

  • 1Department of Pathology, Yonsei University, College of Medicine, Seoul, Korea.

International Journal of Cancer
|January 14, 1998
PubMed
Summary

This study investigated genetic alterations in hepatocellular carcinoma (HCC). Loss of heterozygosity (LOH) was frequent across many chromosome arms, suggesting novel tumor suppressor genes are involved in liver cancer development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Retrospective Review of Real-World Patterns of Biologic Use in Dermatology Across Metropolitan, Regional and Rural Settings.

The Australasian journal of dermatology·2026
Same author

Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21).

ESMO open·2025
Same author

Implementation of an automated, real-time mortality prediction tool in trauma patients: Can it do more than just predict mortality?

Injury·2025
Same author

Percutaneous core needle biopsy of 566 peripheral lung lesions: analysis of factors associated with biopsy failure and postprocedural pneumothorax.

Clinical radiology·2025
Same author

Corrigendum to "An open-label, phase IB/II study of abemaciclib with paclitaxel for tumors with CDK4/6 pathway genomic alterations": [ESMO Open 10 (2025) 104106].

ESMO open·2025
Same author

An open-label, phase IB/II study of abemaciclib with paclitaxel for tumors with CDK4/6 pathway genomic alterations.

ESMO open·2025

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Hepatocellular carcinoma (HCC) is a major global health concern.
  • Understanding the genetic underpinnings of HCC is crucial for developing effective treatments.

Purpose of the Study:

  • To identify genetic events, specifically loss of heterozygosity (LOH), associated with hepatocarcinogenesis.
  • To explore potential novel tumor suppressor genes involved in HCC development and progression.

Main Methods:

  • Analysis of 22 hepatocellular carcinoma (HCC) samples.
  • Examination of non-acrocentric chromosome arms for LOH using 68 polymorphic microsatellite markers.

Main Results:

  • Loss of heterozygosity (LOH) was detected in 92% of chromosome arms across the 22 HCC samples.

Related Experiment Videos

  • High-frequency LOH (>30%) was observed on chromosomes 1q, 4q, 8p, 8q, 10q, 13q, 14q, 16q, and 17p.
  • Novel LOH events were identified on chromosomes 1q and 8q in HCC.

    • Conclusions:

    • The frequent occurrence of LOH across numerous chromosome arms highlights widespread genetic instability in HCC.
    • The identification of novel LOH regions on 1q and 8q suggests the presence of previously unrecognized tumor suppressor genes critical for HCC pathogenesis.